Nanosphere's Q1 Revenues Fall More than 50 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Nanosphere today posted a 56 percent slide in first-quarter revenues that it attributed to delays in regulatory clearance for its new products.

The company reported total revenue of $255,000 for the three-month period ended March 31, 2009, compared to $576,000 in the prior-year period.

For the first quarter of 2009, all of the company's revenues were from product sales. For the prior-year quarter, Nanosphere reported $303,000 in product sales and approximately $273,000 from government grants and contracts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.